Difference between revisions of "About-cancer/treatment/drugs/liver"
Jump to navigation
Jump to search
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Drugs Approved for Liver Cancer == | + | == Drugs Approved for Liver Cancer == <!--T:1--> |
| + | <!--T:2--> | ||
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for liver cancer. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in liver cancer that are not listed here. | This page lists cancer drugs approved by the Food and Drug Administration (FDA) for liver cancer. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in liver cancer that are not listed here. | ||
| + | <!--T:3--> | ||
'''Drugs Approved for Liver Cancer''' | '''Drugs Approved for Liver Cancer''' | ||
| + | <!--T:4--> | ||
Cabometyx (Cabozantinib-S-Malate) | Cabometyx (Cabozantinib-S-Malate) | ||
| + | <!--T:5--> | ||
Cabozantinib-S-Malate | Cabozantinib-S-Malate | ||
| + | <!--T:6--> | ||
Cyramza (Ramucirumab) | Cyramza (Ramucirumab) | ||
| + | <!--T:7--> | ||
Keytruda (Pembrolizumab) | Keytruda (Pembrolizumab) | ||
| + | <!--T:8--> | ||
Lenvatinib Mesylate | Lenvatinib Mesylate | ||
| + | <!--T:9--> | ||
Lenvima (Lenvatinib Mesylate) | Lenvima (Lenvatinib Mesylate) | ||
| + | <!--T:10--> | ||
Nexavar (Sorafenib Tosylate) | Nexavar (Sorafenib Tosylate) | ||
| + | <!--T:11--> | ||
Nivolumab | Nivolumab | ||
| + | <!--T:12--> | ||
Opdivo (Nivolumab) | Opdivo (Nivolumab) | ||
| + | <!--T:13--> | ||
Pembrolizumab | Pembrolizumab | ||
| + | <!--T:14--> | ||
Ramucirumab | Ramucirumab | ||
| + | <!--T:15--> | ||
Regorafenib | Regorafenib | ||
| + | <!--T:16--> | ||
Sorafenib Tosylate | Sorafenib Tosylate | ||
| + | <!--T:17--> | ||
Stivarga (Regorafenib) | Stivarga (Regorafenib) | ||
</translate> | </translate> | ||
Latest revision as of 21:33, 29 October 2019
Drugs Approved for Liver Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for liver cancer. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in liver cancer that are not listed here.
Drugs Approved for Liver Cancer
Cabometyx (Cabozantinib-S-Malate)
Cabozantinib-S-Malate
Cyramza (Ramucirumab)
Keytruda (Pembrolizumab)
Lenvatinib Mesylate
Lenvima (Lenvatinib Mesylate)
Nexavar (Sorafenib Tosylate)
Nivolumab
Opdivo (Nivolumab)
Pembrolizumab
Ramucirumab
Regorafenib
Sorafenib Tosylate
Stivarga (Regorafenib)
